Cardiometabolic Complications of Obesity

Obesity is a major risk factor for cardiometabolic diseases including hypertension, dyslipidemia, atherosclerosis, and heart failure. Excess adiposity induces endothelial dysfunction, vascular inflammation, and altered lipid metabolism, accelerating cardiovascular morbidity and mortality. Insulin resistance and metabolic syndrome further amplify cardiovascular risk. Preventive strategies targeting weight reduction, blood pressure control, and lipid optimization are essential. Advances in imaging, biomarkers, and therapeutic approaches are enabling earlier detection and intervention, ultimately reducing the burden of obesity-associated cardiovascular disease globally.

    Related Conference of Cardiometabolic Complications of Obesity

    October 20-21, 2025

    25th Global Summit on Obesity

    Dubai, UAE
    March 26-27, 2026

    28th Global Obesity Meeting

    London, UK
    June 15-16, 2026

    22nd Euro Obesity and Endocrinology Congress

    Amsterdam, Netherlands

    Cardiometabolic Complications of Obesity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in